loading
전일 마감가:
$0.5035
열려 있는:
$0.494
하루 거래량:
69,985
Relative Volume:
0.47
시가총액:
$19.14M
수익:
$7.88M
순이익/손실:
$-69.20M
주가수익비율:
-0.2451
EPS:
-2.04
순현금흐름:
$-69.73M
1주 성능:
-5.29%
1개월 성능:
-12.28%
6개월 성능:
-32.02%
1년 성능:
-50.50%
1일 변동 폭
Value
$0.485
$0.5241
1주일 범위
Value
$0.485
$0.54
52주 변동 폭
Value
$0.485
$1.56

볼트 바이오테라퓨틱스 Stock (BOLT) Company Profile

Name
명칭
Bolt Biotherapeutics Inc
Name
전화
650-665-9295
Name
주소
900 CHESAPEAKE DRIVE, REDWOOD CITY
Name
직원
100
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
BOLT's Discussions on Twitter

BOLT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
BOLT
Bolt Biotherapeutics Inc
0.50 19.14M 7.88M -69.20M -69.73M -1.83
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
397.27 102.31B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
701.85 77.13B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
623.82 37.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
245.44 31.66B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
113.08 27.11B 3.30B -501.07M 1.03B -2.1146

볼트 바이오테라퓨틱스 Stock (BOLT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-01-06 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2021-03-02 개시 Guggenheim Buy
2021-03-02 개시 Morgan Stanley Overweight
2021-03-02 개시 SVB Leerink Outperform
2021-03-02 개시 Stifel Buy

볼트 바이오테라퓨틱스 주식(BOLT)의 최신 뉴스

pulisher
Dec 14, 2024

BOLT Investors Have the Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - The Eastern Progress Online

Dec 14, 2024
pulisher
Dec 12, 2024

Bolt Biotherapeutics stock hits 52-week low at $0.53 By Investing.com - Investing.com Australia

Dec 12, 2024
pulisher
Dec 12, 2024

Bolt Biotherapeutics stock hits 52-week low at $0.53 - Investing.com India

Dec 12, 2024
pulisher
Dec 08, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bolt Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesBOLT - The Eastern Progress Online

Dec 08, 2024
pulisher
Dec 06, 2024

BOLT Investors Have Opportunity to lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit - The Eastern Progress Online

Dec 06, 2024
pulisher
Nov 30, 2024

We Think Bolt Biotherapeutics (NASDAQ:BOLT) Needs To Drive Business Growth Carefully - Simply Wall St

Nov 30, 2024
pulisher
Nov 26, 2024

Bolt Biotherapeutics (BOLT) Stock Surges Amid Biotech Sector Mov - GuruFocus.com

Nov 26, 2024
pulisher
Nov 20, 2024

Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

Bolt Biotherapeutics stock hits 52-week low at $0.54 By Investing.com - Investing.com Canada

Nov 19, 2024
pulisher
Nov 19, 2024

Bolt Biotherapeutics stock hits 52-week low at $0.54 - Investing.com

Nov 19, 2024
pulisher
Nov 16, 2024

HC Wainwright Issues Pessimistic Forecast for BOLT Earnings - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

Bolt Biotherapeutics Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 15, 2024
pulisher
Nov 14, 2024

Bolt Biotherapeutics’ Restructuring Faces Potential Setbacks: A Closer Look - TipRanks

Nov 14, 2024
pulisher
Nov 13, 2024

Bolt Biotherapeutics Reports Q3 2024 Financial Results - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times

Nov 13, 2024
pulisher
Nov 12, 2024

Bolt Biotherapeutics Inc.: Q3 Earnings Snapshot - Houston Chronicle

Nov 12, 2024
pulisher
Nov 09, 2024

Here's Why We're Watching Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Situation - Yahoo Finance

Nov 09, 2024
pulisher
Nov 07, 2024

BOLTBolt Biotherapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 07, 2024
pulisher
Nov 07, 2024

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting - The Manila Times

Nov 07, 2024
pulisher
Nov 05, 2024

Atara Biotherapeutics to Announce Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - Marketscreener.com

Nov 05, 2024
pulisher
Nov 02, 2024

Bolt Biotherapeutics (STU:6LP) Cash Flow from Investing : €52.47 Mil (TTM As of Jun. 2024) - GuruFocus.com

Nov 02, 2024
pulisher
Oct 30, 2024

Breast Cancer Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - Barchart

Oct 30, 2024
pulisher
Oct 22, 2024

BOLT Stock Surges Over 5% Amidst Biotech Sector's Mixed Performa - GuruFocus.com

Oct 22, 2024
pulisher
Oct 18, 2024

Scrip Asks…What Does 2023 Hold For Biopharma? Part 5: Technological Advances - Citeline

Oct 18, 2024
pulisher
Oct 16, 2024

Bolt Biotherapeutics (BOLT) Stock Surges Amid Broad Biotech Indu - GuruFocus.com

Oct 16, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Sells 240,898 Shares of Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) - Defense World

Oct 13, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Has $208,000 Stock Holdings in Hesai Group (NASDAQ:HSAI) - Defense World

Oct 13, 2024
pulisher
Oct 12, 2024

Short Interest in Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Drops By 39.1% - Defense World

Oct 12, 2024
pulisher
Oct 11, 2024

Just Auto Excellence Awards 2024: TomTom - just-auto.com

Oct 11, 2024
pulisher
Oct 07, 2024

Bolt Biotherapeutics (BOLT) Stock Surges Amid Biotech Sector Vol - GuruFocus.com

Oct 07, 2024
pulisher
Sep 28, 2024

Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Short Interest Down 14.2% in September - Defense World

Sep 28, 2024
pulisher
Sep 24, 2024

Bolt Biotherapeutics stock hits 52-week low at $0.61 By Investing.com - Investing.com Canada

Sep 24, 2024
pulisher
Sep 24, 2024

Bolt Biotherapeutics stock hits 52-week low at $0.61 - Investing.com

Sep 24, 2024
pulisher
Sep 19, 2024

Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Sees Significant Decrease in Short Interest - Defense World

Sep 19, 2024
pulisher
Sep 07, 2024

Bolt Biotherapeutics stock hits 52-week low at $0.65 By Investing.com - Investing.com Australia

Sep 07, 2024
pulisher
Sep 06, 2024

Bolt Biotherapeutics stock hits 52-week low at $0.65 - Investing.com

Sep 06, 2024
pulisher
Sep 05, 2024

Bolt Biotherapeutics Announces Changes to its Board of Directors - ForexTV.com

Sep 05, 2024

볼트 바이오테라퓨틱스 (BOLT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
자본화:     |  볼륨(24시간):